More about Narayana Hrudayalaya Limited
Fundamentals for Narayana Hrudayalaya Limited
Regulatory Filings for Narayana Hrudayalaya Limited
IndiGo Implements Steep Fuel Surcharge as Iran Conflict Sends Jet Fuel Costs Soaring
The RBI's New Forex Fortress: Defensive Maneuvers in an Era of Oil Shocks
India's Fiscal Milestone: GST Collections Breach ₹2 Lakh Crore Mark for the First Time
AI Disruption Accelerates: Oracle Layoffs Raise Alarms for India’s Tech Workforce
Fundamentals for Narayana Hrudayalaya Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company engages in health insurance business. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
Revenue projections:
The projected decline in NH's revenues compared to last year is expected to make investors cautious. A drop in revenue often has a direct negative effect on the company's bottom line, signaling potential challenges that could undermine investor confidence and reduce overall profitability.
Financial Ratios:
| currentRatio | 2.146000 |
|---|---|
| forwardPE | 29.462645 |
| debtToEquity | 57.614000 |
| earningsGrowth | 0.301000 |
| revenueGrowth | 0.174000 |
| grossMargins | 0.410410 |
| operatingMargins | 0.191650 |
| trailingEps | 41.570000 |
| forwardEps | 59.285240 |
Narayana Hrudayalaya Limited's current ratio of 2.146 highlights the company's ability to easily cover its short-term debt using its available cash and assets. This indicates a strong liquidity position, ensuring Narayana Hrudayalaya Limited is unlikely to face difficulties in meeting immediate financial obligations.
NH's Forward PE is within a good range, showing that the stock price compares well to its earnings. This suggests it isn't overpriced and leaves room for growth, making the stock appealing to investors looking for value and growth opportunities.
NH's positive earnings and revenue growth indicate that the company is well-positioned for business expansion. This growth suggests a strong financial trajectory, with NH expected to continue increasing its profits and revenue in the coming periods.
Narayana Hrudayalaya Limited's forward EPS being higher than its trailing EPS points to expected growth in profitability. This suggests that the company is projected to perform better in the current financial year, with higher earnings forecasted compared to the previous year.
Price projections:
The stock price of NH has often been near the lower end of projections, indicating that it may not be meeting investor expectations. This trend could suggest challenges ahead for the company.
Insider Transactions:
1 sales transactions of Narayana Hrudayalaya Limited were conducted, with market price at 1957.300048828125.There were no sell transactions throughout the period under consideration.The recent trend of more purchases than sales at Narayana Hrudayalaya Limited's current price could signal investor optimism. This pattern may point to a positive outlook for the stock, as it indicates growing confidence in its potential to perform well in the future.
Recommendation changes over time:
NH has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view NH as a reliable choice for their money, offering a promising avenue for future growth and financial gains.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
U.S. Labor Market in 2026: JOLTS and Consumer Confidence Reveal Why Hiring Cooled Without Unemployment Spike
Lending Unleashed: Assessing the Impact of the Federal Reserve’s Capital Rollback
Calendar Collision: How Mahavir Jayanti's Overlap With Fiscal Year-End Reshapes India's Tax-Loss Harvesting Landscape